BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 35142001)

  • 21. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.
    Chiloiro G; Cusumano D; de Franco P; Lenkowicz J; Boldrini L; Carano D; Barbaro B; Corvari B; Dinapoli N; Giraffa M; Meldolesi E; Manfredi R; Valentini V; Gambacorta MA
    Radiol Med; 2022 Jan; 127(1):11-20. PubMed ID: 34725772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning-based response assessment in patients with rectal cancer after neoadjuvant chemoradiotherapy: radiomics analysis for assessing tumor regression grade using T2-weighted magnetic resonance images.
    Lee YD; Kim HG; Seo M; Moon SK; Park SJ; You MW
    Int J Colorectal Dis; 2024 May; 39(1):78. PubMed ID: 38789861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editorial for "Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics".
    Viswanath SE
    J Magn Reson Imaging; 2022 Oct; 56(4):1143-1144. PubMed ID: 35244965
    [No Abstract]   [Full Text] [Related]  

  • 24. Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics.
    Bulens P; Couwenberg A; Intven M; Debucquoy A; Vandecaveye V; Van Cutsem E; D'Hoore A; Wolthuis A; Mukherjee P; Gevaert O; Haustermans K
    Radiother Oncol; 2020 Jan; 142():246-252. PubMed ID: 31431368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI-based pre-Radiomics and delta-Radiomics models accurately predict the post-treatment response of rectal adenocarcinoma to neoadjuvant chemoradiotherapy.
    Wang L; Wu X; Tian R; Ma H; Jiang Z; Zhao W; Cui G; Li M; Hu Q; Yu X; Xu W
    Front Oncol; 2023; 13():1133008. PubMed ID: 36925913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comprehensive Prediction Model Based on MRI Radiomics and Clinical Factors to Predict Tumor Response After Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Jiang H; Guo W; Yu Z; Lin X; Zhang M; Jiang H; Zhang H; Sun Z; Li J; Yu Y; Zhao S; Hu H
    Acad Radiol; 2023 Sep; 30 Suppl 1():S185-S198. PubMed ID: 37394412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
    Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
    [No Abstract]   [Full Text] [Related]  

  • 28. Development and Validation of a Radiomics Model Based on Lymph-Node Regression Grading After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Zhang S; Tang B; Yu M; He L; Zheng P; Yan C; Li J; Peng Q
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):821-833. PubMed ID: 37230433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Yi X; Pei Q; Zhang Y; Zhu H; Wang Z; Chen C; Li Q; Long X; Tan F; Zhou Z; Liu W; Li C; Zhou Y; Song X; Li Y; Liao W; Li X; Sun L; Pei H; Zee C; Chen BT
    Front Oncol; 2019; 9():552. PubMed ID: 31293979
    [No Abstract]   [Full Text] [Related]  

  • 30. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy.
    Cui Y; Song M; Tie J; Li S; Wang H; Zhang Y; Geng J; Liu Z; Teng H; Sui X; Zhu X; Cai Y; Li Y; Wang W
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):176. PubMed ID: 38575793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study.
    Wei Q; Chen Z; Tang Y; Chen W; Zhong L; Mao L; Hu S; Wu Y; Deng K; Yang W; Liu X
    Eur Radiol; 2023 Mar; 33(3):1906-1917. PubMed ID: 36355199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local tuning of radiomics-based model for predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Tang B; Lenkowicz J; Peng Q; Boldrini L; Hou Q; Dinapoli N; Valentini V; Diao P; Yin G; Orlandini LC
    BMC Med Imaging; 2022 Mar; 22(1):44. PubMed ID: 35287607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI.
    Yardimci AH; Kocak B; Sel I; Bulut H; Bektas CT; Cin M; Dursun N; Bektas H; Mermut O; Yardimci VH; Kilickesmez O
    Jpn J Radiol; 2023 Jan; 41(1):71-82. PubMed ID: 35962933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study.
    Xiang Y; Li S; Wang H; Song M; Hu K; Wang F; Wang Z; Niu Z; Liu J; Cai Y; Li Y; Zhu X; Geng J; Zhang Y; Teng H; Wang W
    Clin Transl Radiat Oncol; 2023 Jan; 38():175-182. PubMed ID: 36471751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a multi-modal ultrasomics model to predict response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Qin Q; Gan X; Lin P; Pang J; Gao R; Wen R; Liu D; Tang Q; Liu C; He Y; Yang H; Wu Y
    BMC Med Imaging; 2024 Mar; 24(1):65. PubMed ID: 38500022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of locally advanced rectal cancer response to neoadjuvant chemoradiation therapy using volumetric multiparametric MRI-based radiomics.
    El Homsi M; Bane O; Fauveau V; Hectors S; Vietti Violi N; Sylla P; Ko HB; Cuevas J; Carbonell G; Nehlsen A; Vanguri R; Viswanath S; Jambawalikar S; Shaish H; Taouli B
    Abdom Radiol (NY); 2024 Mar; 49(3):791-800. PubMed ID: 38150143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep learning radiomics-based prediction of distant metastasis in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A multicentre study.
    Liu X; Zhang D; Liu Z; Li Z; Xie P; Sun K; Wei W; Dai W; Tang Z; Ding Y; Cai G; Tong T; Meng X; Tian J
    EBioMedicine; 2021 Jul; 69():103442. PubMed ID: 34157487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative prediction of perineural invasion of rectal cancer based on a magnetic resonance imaging radiomics model: A dual-center study.
    Liu Y; Sun BJ; Zhang C; Li B; Yu XX; Du Y
    World J Gastroenterol; 2024 Apr; 30(16):2233-2248. PubMed ID: 38690027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-enhanced MRI for T Restaging of Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy and Radiation Therapy.
    Lu QY; Guan Z; Zhang XY; Li XT; Sun RJ; Li QY; Sun YS
    Radiology; 2022 Nov; 305(2):364-372. PubMed ID: 35852424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.